Method of fenbendazole encapsulation

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention relates to the chemical-pharmaceutical industry and represents a method of medication encapsulation by precipitation with a non-solvent, which is characterised by the fact that as the medication used is fenbendazole, and as an envelope - sodium carboxymethylcellulose, which is precipitated from a solution in diethyl ether by the addition as the non-solvent of carbinol and water at 25°C.

EFFECT: invention ensures the simplification and acceleration of the process of obtaining microcapsules, reduction of loss in obtaining the microcapsules (increase of output by weight).

3 ex

 

The invention relates to the field of encapsulation, and in particular to obtaining microcapsules of fenbendazol.

Previously known methods for producing microcapsules of drugs. So, in us Pat. 2092155, IPC A61K 047/02, A61K 009/16 published 10.10.1997, Russian Federation, proposed a method for microencapsulation of drugs, based on the use of irradiation with ultraviolet rays.

The disadvantages of this method are the duration of the process and application of ultraviolet radiation, which can influence the formation of microcapsules.

In us Pat. 2091071, IPC A61K 35/10, Russian Federation, published 27.09.1997, a method of producing the drug by dispersing in a ball mill to obtain microcapsules.

The disadvantage of this method is the application of the ball mill and the duration of the process.

In us Pat. 2101010, IPC A61K 9/52, A61K 9/50, A61K 9/22, A61K 9/20, A61K 31/19, Russian Federation, published 10.01.1998 proposed chewable form of the drug with taste masking, having the properties of a controlled release drug product that contains microcapsules with a size of 100-800 microns in diameter and consists of pharmaceutical kernel crystalline ibuprofen and polymeric coating comprising a plasticizer, elastic enough to resist chewing. P�likernoe coating is a copolymer based on methacrylic acid.

Disadvantages of the invention: use of a copolymer based on methacrylic acid, as these polymer coatings can cause cancer; the difficulty of execution; the duration of the process.

In us Pat. 2173140, IPC A61K 009/50, A61K 009/127, Russian Federation, published 10.09.2001, a method of producing kremnijorganicheskih microcapsules using a rotary cavitation equipment with high shear forces and powerful hydroacoustic phenomena sonic and ultrasonic range for dispersion.

The disadvantage of this method is the use of special equipment - rotary-cavitational installation, which has the ultrasonic effect, which influences the formation of the microcapsules and thus may cause adverse reactions due to the fact that ultrasound has a destructive effect on polymers of protein nature, therefore, the proposed method is applicable when working with polymers of synthetic origin.

In us Pat. 2359662, IPC A61K 009/56, A61J 003/07, B01J 013/02, A23L 001/00 published 27.06.2009, Russian Federation, proposed a method of producing microcapsules using spray cooling in the spray tower Niro under the following conditions: air temperature at the inlet 10°C, the temperature at the outlet 28°C, the speed of rotation of the spray drum 10000 turnover�in/min. Microcapsules according to the invention have improved stability and provide adjustable and/or prolonged release of the active ingredient.

The disadvantages of the proposed method are the duration of the process and the use of special equipment, certain set of conditions (the air temperature at the inlet 10°C, the temperature at the outlet 28°C, the speed of rotation of the spray drum 10000 rpm/min).

The closest method is the method proposed in us Pat. 2134967, IPC A01N 53/00, A01N 25/28, published 27.08.1999 G., Russian Federation (1999). In water dispersed solution of a mixture of natural lipids and PYRETHROID insecticide in a weight ratio of 2-4:1 in an organic solvent, which leads to simplification of the method of microencapsulation.

The disadvantage is the dispersion in an aqueous medium, which makes the proposed method applicable for obtaining microcapsules of water-soluble drugs in water-soluble polymers.

The technical objective is the simplification and acceleration of the process of production of microcapsules, reducing loss upon receipt of the microcapsules (increase of the yield by weight).

The solution of a technical problem is achieved by a method of encapsulation of fenbendazol, characterized in that as the shell of the microcapsules used sodium carboxymethylcellulose when receiving physical-x�chemical method of deposition by nerastvorim using two precipitators - carbinol and diethyl ether, the process is carried out without special equipment.

A distinctive feature of the proposed method is the use of sodium carboxymethylcellulose as the shell of the microcapsules, of fenbendazole as their nucleus, and the use of two precipitators - carbinol and diethyl ether.

The result of the proposed method are obtaining microcapsules of fenbendazol in the sodium carboxymethyl cellulose at 25°C for 20 minutes. The output of the microcapsules is more than 90%.

EXAMPLE 1. Obtaining microcapsules of fenbendazol with the dissolution of the drug in dioxane, the ratio of the core/polymer 1:3

100 mg of fenbendazol dissolved in 1 ml of dioxane and the resulting mixture is dispersed in a solution of sodium carboxymethyl cellulose in diethyl ether containing the specified 300 mg of the polymer in the presence of 0.01 g of the drug E472c under stirring about 1000/sec. Next, pour 2 ml of carbinol and 1 ml of distilled water. The resulting suspension was filtered and dried at room temperature.

Received 0,396 g of a white to yellowish powder. The yield was 99%.

EXAMPLE 2 Obtaining microcapsules of fenbendazol with the dissolution of the drug in dimethyl sulfoxide (DMSO), the ratio of the core/polymer 1:3

100 mg of fenbendazol dissolved in 1 ml DMSO and the resulting mixture is dispersed in a solution of n�of try of carboxymethyl cellulose in diethyl ether, containing the specified 300 mg of the polymer in the presence of 0.01 g of the drug E472c under stirring about 1000/sec. Next, pour 2 ml of carbinol and 1 ml of distilled water. The resulting suspension was filtered and dried at room temperature.

Received 0,396 g of a white to yellowish powder. The yield was 99%.

EXAMPLE 3 Obtaining microcapsules of fenbendazol with the dissolution of the drug in dimethylformamide (DMF), the ratio of the core/polymer 1:3

100 mg of fenbendazol dissolved in 1 ml DMF and the resulting mixture is dispersed in a solution of sodium carboxymethyl cellulose in diethyl ether containing the specified 300 mg of the polymer in the presence of 0.01 g of the drug E472c under stirring about 1000/sec. Next, pour 2 ml of carbinol and 1 ml of distilled water. The resulting suspension was filtered and dried at room temperature.

Received 0,396 g of a white to yellowish powder. The yield was 99%.

The obtained microcapsules of fenbendazol physico-chemical deposition method by nerastvorim using two precipitators - carbinol and diethyl ether, thereby increasing the output and accelerates the process of microencapsulation. The process is simple to perform and lasts for 20 minutes, requires no special equipment.

The proposed method is suitable for the veterinary industry due to the minimal loss of speed, ease of acquisition and allocation of microcapsules.

Method of encapsulation of the drug by the method of deposition by aristotelem, characterized in that the medicinal product is used fenbendazol, as the shell - sodium carboxymethylcellulose, which is precipitated from solution in diethyl ether by adding as herstories carbinol and water at 25°C.



 

Same patents:

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention relates to the chemical-pharmaceutical industry and represents a method of medication encapsulation by precipitation with a non-solvent, which is characterised by the fact that as the medication used is fenbendazole, and as an envelope - sodium carboxymethylcellulose, which is precipitated from a solution in diethyl ether by the addition as the non-solvent of isopropanol and water at 25°C.

EFFECT: invention ensures the simplification and acceleration of the process of obtaining microcapsules, reduction of loss in obtaining the microcapsules (increase of output by weight).

3 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention relates to the chemical-pharmaceutical industry and represents a method of medication encapsulation by a method of precipitation with a non-solvent, characterised by the fact that as the medication used is fenbendazole and as an envelope sodium carboxymethylcellulose, which is precipitated from a solution in dicloromethane by the addition of carbinol as the non-solvent and water at 25°C.

EFFECT: invention ensures the simplification and acceleration of the process of obtaining microcapsules, reduction of loss in obtaining the microcapsules (increase of output by weight).

3 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention relates to the chemical-pharmaceutical industry and represents a method of medication encapsulation by a method of precipitation with a non-solvent, characterised by the fact that as the medication used is fenbendazole and as an envelope sodium carboxymethylcellulose, which is precipitated from a solution in toluene by the addition of isopropanol as the non-solvent and water at 25°C.

EFFECT: invention ensures the simplification and acceleration of the process of obtaining microcapsules, reduction of loss in obtaining the microcapsules (increase of output by weight).

3 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention relates to the chemical-pharmaceutical industry and represents a method of medication encapsulation by a method of precipitation with a non-solvent, characterised by the fact that as the medication used is fenbendazole and as an envelope - sodium carboxymethylcellulose, which is precipitated from a solution in chloroform by the addition of isopropanol as the non-solvent and water at 25°C.

EFFECT: invention ensures the simplification and acceleration of the process of obtaining microcapsules, reduction of loss in obtaining the microcapsules (increase of output by weight).

3 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention relates to the chemical-pharmaceutical industry and represents a method of medication encapsulation by a method of precipitation with a non-solvent, characterised by the fact that as the medication used is fenbendazole and as an envelope sodium carboxymethylcellulose, which is precipitated from a solution in acetyl acetate by the addition of isopropanol as the non-solvent and water at 25°C.

EFFECT: invention ensures the simplification and acceleration of the process of obtaining microcapsules, reduction of loss in obtaining the microcapsules (increase of output by weight).

3 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention relates to the chemical-pharmaceutical industry and represents a method of medication encapsulation by a method of precipitation with a non-solvent, characterised by the fact that as the medication used is fenbendazole and as an envelope sodium carboxymethylcellulose, which is precipitated from a solution in cyclohexanol by the addition of ethanol as the non-solvent and water at 25°C.

EFFECT: invention ensures the simplification and acceleration of the process of obtaining microcapsules, reduction of loss in obtaining the microcapsules (increase of output by weight).

3 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to producing drug preparations, namely represents a process of producing microcapsules of the antiseptic Dorogov's stimulator (ADS fraction 2). The process of microencapsulation represents a method of a non-solvent addition; a microcapsule coating is kappa-carageenan, while a core is the ADS fraction 2.

EFFECT: implementing the invention provides simplifying and accelerating the process of microencapsulation, reduces the microencapsulation loss (higher weight yield).

1 dwg, 2 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to medicine, namely to pharmaceutics, particularly to a method for producing calcium chloride microcapsules possessing supramolecular properties by a non-solvent addition differing by dissolving calcium chloride in water and dispersing in a carageenan suspension used as a microcapsule coating, in ethanol in the presence of the preparation E472c; that is followed by adding isopropanol, filtering and drying at room temperature.

EFFECT: implementing the invention enables simplifying and fastening the process of the microcapsule preparation and increasing higher microcapsule yield by physical-chemical method of the non-solvent addition.

2 ex, 12 dwg

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to the chemical-pharmaceutical industry, and represents a method for producing drug microcapsules by a non-solvent addition differing by the fact that the drugs represent cephalosporins, while the coating is human serum albumin deposited from an aqueous solution by adding carbinol as the non-solvent and isopropanol at 25°C.

EFFECT: invention provides simplifying and fastening the microencapsulation process, reducing the microencapsulation loss (higher weight yield).

3 ex

FIELD: chemistry.

SUBSTANCE: in the process of obtaining microcapsules by a physical-chemical method of precipitation by means of a non-solvent, a heterocyclic compound is dissolved in DMSO, the obtained solution is transferred into a PVP water solution, the first precipitating agent - a mixture of acetic acid in acetone, containing octyl ether of acridonacetic acid (OeAAA) as SAS, is added, and after that, the second precipitating agent - a mixture of OeAAA in acetone is added, the obtained suspension is filtered, washed with acetone and dried.

EFFECT: realisation of the invention makes it possible to simplify the process of obtaining microcapsules and increase the output by weight.

3 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention relates to the chemical-pharmaceutical industry and represents a method of medication encapsulation by precipitation with a non-solvent, which is characterised by the fact that as the medication used is fenbendazole, and as an envelope - sodium carboxymethylcellulose, which is precipitated from a solution in diethyl ether by the addition as the non-solvent of isopropanol and water at 25°C.

EFFECT: invention ensures the simplification and acceleration of the process of obtaining microcapsules, reduction of loss in obtaining the microcapsules (increase of output by weight).

3 ex

FIELD: chemistry.

SUBSTANCE: invention relates to a method of encapsulating fenbendazole. Said method is characterised by that fenbendazole is dissolved in dioxane or dimethyl formamide, then dispersed in a mixture of sodium carboxymethyl cellulose and butanol in the presence of E472c, followed by addition of isopropanol and water, and filtering and drying the obtained suspension of microcapsules.

EFFECT: method provides a simple and fast process of producing microcapsules and increases mass output.

3 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention relates to the chemical-pharmaceutical industry and represents a method of medication encapsulation by a method of precipitation with a non-solvent, characterised by the fact that as the medication used is fenbendazole and as an envelope sodium carboxymethylcellulose, which is precipitated from a solution in dicloromethane by the addition of carbinol as the non-solvent and water at 25°C.

EFFECT: invention ensures the simplification and acceleration of the process of obtaining microcapsules, reduction of loss in obtaining the microcapsules (increase of output by weight).

3 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention relates to the chemical-pharmaceutical industry and represents a method of medication encapsulation by a method of precipitation with a non-solvent, characterised by the fact that as the medication used is fenbendazole and as an envelope sodium carboxymethylcellulose, which is precipitated from a solution in toluene by the addition of isopropanol as the non-solvent and water at 25°C.

EFFECT: invention ensures the simplification and acceleration of the process of obtaining microcapsules, reduction of loss in obtaining the microcapsules (increase of output by weight).

3 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention relates to the chemical-pharmaceutical industry and represents a method of medication encapsulation by a method of precipitation with a non-solvent, characterised by the fact that as the medication used is fenbendazole and as an envelope - sodium carboxymethylcellulose, which is precipitated from a solution in chloroform by the addition of isopropanol as the non-solvent and water at 25°C.

EFFECT: invention ensures the simplification and acceleration of the process of obtaining microcapsules, reduction of loss in obtaining the microcapsules (increase of output by weight).

3 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to medicine and consists in a method for intestevit encapsulation. Implementing the method involves dissolving 100 mg of intestevit in 1 ml of dioxane, or dimethylsulphoxide, or dimethylformamide, dispersing the prepared mixture in a sodium carboxymethylcellulose solution in acetone containing 300 ml of the above polymer in the presence of 0.01 g of the preparation E472 while stirring, adding 1 ml of distilled water, and filtering and drying the prepared suspension.

EFFECT: simplifying and fastening the process of microcapsules obtaining, reducing the loss accompanying the microencapsulation process.

3 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention relates to the chemical-pharmaceutical industry and represents a method of medication encapsulation by a method of precipitation with a non-solvent, characterised by the fact that as the medication used is fenbendazole and as an envelope sodium carboxymethylcellulose, which is precipitated from a solution in acetyl acetate by the addition of isopropanol as the non-solvent and water at 25°C.

EFFECT: invention ensures the simplification and acceleration of the process of obtaining microcapsules, reduction of loss in obtaining the microcapsules (increase of output by weight).

3 ex

FIELD: chemistry.

SUBSTANCE: invention relates to microencapsulation, particularly to a method of producing zinc oxide microcapsules. The method is characterised by that the microcapsule shell used is carrageenan, wherein a weighed portion of zinc oxide in dimethylsulphoxide is mixed with a suspension of carrageenan in butanol in the presence of an E472c surfactant; ethanol is added to the obtained suspension as a precipitant; the obtained suspension is filtered and dried at room temperature.

EFFECT: method provides a simple and faster process of producing zinc oxide microcapsules, reduces losses when producing microcapsules.

3 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention relates to the chemical-pharmaceutical industry and represents a method of medication encapsulation by a method of precipitation with a non-solvent, characterised by the fact that as the medication used is fenbendazole and as an envelope sodium carboxymethylcellulose, which is precipitated from a solution in cyclohexanol by the addition of ethanol as the non-solvent and water at 25°C.

EFFECT: invention ensures the simplification and acceleration of the process of obtaining microcapsules, reduction of loss in obtaining the microcapsules (increase of output by weight).

3 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to medicine and describes a method for fenbendazole encapsulation, which involves dissolving fenbendazole in dioxane 1 ml and dispersing the prepared mixture into a sodium carboxymethyl cellulose solution in dioxane containing 300 mg of the above polymer in the presence of the preparation E472c at agitation at 1,000 rpm, adding 2 ml of carbinol and 1 ml of distilled water; the prepared suspension is filtered and dried at room temperature.

EFFECT: simplifying and fastening the process of microencapsulation, reducing the process accompanying losses and increasing the weight yield.

3 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention relates to the field of encapsulation, in particular to a method of obtaining fenbendazole microcapsules in an envelope of sodium carboxymethylcellulose. In accordance with the method fenbendazole is dissolved in dioxane or dimethylsulphoxide, or dimethylformamide, the obtained fenbendazole solution is added to a solution of sodium carboxymethylcellulose in methanol in the presence of E472c with mixing at a rate of 1000 rev/s. Fenbendazole and sodium carboxymethylcellulose are taken in a weight ratio of 1:3. After that ethanol and distilled water, taken in a ratio of 2:1 vol/vol, are added. The obtained suspension of microcapsules is filtered and dried. The process is realised at 25°C for 20 minutes.

EFFECT: invention ensures the simplification and acceleration of the process of obtaining microcapsules, reduction of loss in their obtaining (increase of output by weight).

3 ex

Up!